Home » Business » Manufacturing
Sanofi agrees to acquire Chattem
FRENCH drug maker Sanofi-Aventis SA yesterday said it has agreed to buy United States health care company Chattem Inc for about US$1.9 billion in cash in a deal it said would create the world's fifth-largest consumer healthcare company.
Paris-based Sanofi-Aventis said it will offer US$93.50 per share to acquire 100 percent of Chattem, a Tennessee-based maker of consumer health care products such as Gold Bond skin care creams and Icy Hot pain relief medicine.
In a statement, Sanofi-Aventis said it will launch its public tender offer for Chattem in January, and it expects to complete the acquisition in the first quarter of 2010.
Chattem's management will remain in place following the takeover, Sanofi-Aventis said.
The French firm said it would maintain both of Chattem's existing plants in Chattanooga and will continue construction on a third.
Last year Chattem had 488 employees and reported revenue of US$455 million.
Paris-based Sanofi-Aventis said it will offer US$93.50 per share to acquire 100 percent of Chattem, a Tennessee-based maker of consumer health care products such as Gold Bond skin care creams and Icy Hot pain relief medicine.
In a statement, Sanofi-Aventis said it will launch its public tender offer for Chattem in January, and it expects to complete the acquisition in the first quarter of 2010.
Chattem's management will remain in place following the takeover, Sanofi-Aventis said.
The French firm said it would maintain both of Chattem's existing plants in Chattanooga and will continue construction on a third.
Last year Chattem had 488 employees and reported revenue of US$455 million.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.